According to media reports, the pharmaceutical company’s export revenue declined 47% to about $36 million in February, reflecting a significant slowdown in overseas sales.
Laurus Labs is a research-driven pharmaceutical and biotechnology company. It holds a leadership position in developing and manufacturing select Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDF) across anti-retroviral, oncology, cardiovascular, and gastro therapeutics.
On a consolidated basis, Laurus Labs net profit rose 172.65% to Rs 251.66 crore while net sales rose 25.67% to Rs 1778.29 crore in Q3 December 2025 over Q3 December 2024.